STANFORD RESEARCHER SHOWS POSITIVE RESULTS OF NEW CHEMOTHERAPY COMBINATION FOR COLON CANCER 6/1/03 News Release In the initial 16 patients who had never before received chemotherapy, 75 percent of the tumors shrank with the combination of Iressa and FOLFOX compared to 38 percent with FOLFOX alone. In those whose previous chemotherapy had not been successful, 29 percent of the tumors shrank compared with 9 percent using FOLFOX alone. http://mednews.stanford.edu/news_releases_html/2003/junerelease/Iressa.htm